Developer docs
API playgroundTry for free, no card

Search company profiles

Progeneron

Full company profile

uuid0024dzv

Namestring
Progeneron
Legal namestring
Progeneron, LLC
Websiteurl
progeneron.net
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Progeneron is a privately held research company headquartered in Aliso Viejo, California, that develops and manufactures natural and naturally derived topically applied products for hand and skin conditions. The company's only commercial product is Progeneron Hand Cream, a surgeon-developed daily-use formulation created by founder and Chief Medical Officer Dr. David Scharp, MD, to mitigate the progression and symptoms of Palmar Fibromatosis and to address general aging-hand issues including arthritis pain and reduced range of mobility. The formulation has been evaluated in a 180-day IRB safety study in which 95% of participants showed no signs of disease progression, forming the company's primary clinical evidence platform and differentiating claim.

The company's revenue model is a direct-to-consumer e-commerce operation built on a Shopify storefront at progeneron.net, with fulfillment delegated to Eresina, LLC and shipping handled via FedEx to the United States and Canada. Go-to-market combines consumer-facing content (website, blog, email newsletter) with a parallel physician channel via the Progeneron Physician Portal, where physicians can access clinical data and recommend the product to patients. Pricing is not publicly disclosed; one-time, pay-as-you-go purchase is the only commercial transaction type. The company reports no app, no API surface, no patents or trademarks, no disclosed funding rounds, and no institutional investors.

Progeneron operates as a founder-led micro-business (11-50 employees) with a single-SKU portfolio, a North-American geographic footprint, and no evident institutional capital or third-party scale signals in available sources. Business momentum is anchored almost entirely on the founder's credentials, the IRB study outcome, and a niche, condition-specific value proposition that targets aging-hand consumers and Palmar Fibromatosis patients — a small but underserved therapeutic niche where limited competing therapeutic options exist.

Short descriptiontext

Progeneron is a privately held California-based research company that develops and sells a single surgeon-developed topical hand cream for Palmar Fibromatosis and aging-hand conditions through its own e-commerce store, serving individual consumers in the US and Canada.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAliso Viejo, United States
HQ citystring
Aliso Viejo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
topical hand cream, palmar fibromatosis treatment, aging hand skincare, physician formulated cream, arthritis hand relief
Industry1 code
PRIMARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SIC code1 code
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Topical Dermatological Skincare
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1E-commerce Product Sales
TypeOne Time License
Description

Direct-to-consumer sales of Progeneron Hand Cream through their online store. One-time purchase model for topical hand cream products.

progeneron.net
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Hand cream product pricing
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Price not listed on website

progeneron.net
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Progeneron develops and manufactures Progeneron Hand Cream, a surgeon-developed daily-use topical cream formulated from natural and naturally derived ingredients to mitigate the progression of Palmar Fibromatosis, reduce arthritis pain, and improve range and mobility in aging hands. The product was the subject of a 180-day IRB safety study in which 95% of participants showed no signs of disease progression. Progeneron sells the cream direct-to-consumer through its Shopify-powered e-commerce site and supports physicians with clinical data via a dedicated Physician Portal.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 95% of IRB study participants showed no signs of Palmar Fibromatosis disease progression over 180 days
+1 more record
Product overview1 text field

Progeneron offers a single core product — the Progeneron Hand Cream. This surgeon-developed daily-use hand cream is designed to mitigate symptoms associated with Palmar Fibromatosis and general aging hands, including arthritis pain and reduced mobility. The company was founded by Dr. David Scharp, MD, and operates as a research company focusing on natural and naturally derived topically applied products for hand and skin conditions. All products are developed and manufactured in the USA.

Product and service1 record
1Progeneron Hand Cream
CategoryTopical Dermatological Skincare
Description

A surgeon-developed daily-use hand cream formulated to mitigate the progression and symptoms associated with Palmar Fibromatosis, reduce arthritis pain, and increase range and mobility in aging hands. Subject to a 180-day IRB safety study in which 95% of participants showed no signs of disease progression. Sold direct-to-consumer through the Progeneron website, with clinical data accessible to physicians through a dedicated Physician Portal.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Eresina, LLC
Strategic tierCoreTypeOthers
Description

Eresina, LLC handles order fulfillment and shipping operations for Progeneron. All orders are processed by Eresina, LLC within 3 business days. They are responsible for customs, duties, and taxes processing and currently ship only to United States and Canada.

progeneron.net
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Topical pain-relief brand (menthol-based) widely used by chiropractors, physical therapists, and consumers for arthritis and musculoskeletal pain. Comparable as a clinical-channel topical therapy sold through both professional recommendation and retail.

TypeDirect peer
Description

Direct-to-consumer topical pain-relief brand targeting joint, muscle, and inflammation-related discomfort. Comparable DTC marketing approach and arthritis-pain value proposition to Progeneron Hand Cream.

TypeBroad incumbent
Description

Beiersdorf-owned medical skincare brand with a strong line of therapeutic hand creams and skin-condition products recommended by dermatologists. Directly comparable in the medical-grade hand-care category but with global distribution and a much broader portfolio.

TypeDirect peer
Description

US-based topical pain-relief brand targeting arthritis, joint, and muscle pain with emu-oil-based formulations sold in drugstores and mass retail. Directly comparable as a topical therapy for arthritis and aging-hand symptoms in a similar price-and-channel band.

TypeBroad incumbent
Description

Johnson & Johnson-owned skincare brand with hand and body care lines positioned at the medical-grade end of mass-market skincare. Comparable consumer-skincare category and brand authority, but with vastly greater distribution and product breadth.

6Gold Bond
TypeBroad incumbent
Description

Sanofi-owned therapeutic body and hand lotion brand widely distributed in US drugstores and supermarkets. Comparable target consumer (aging hands, daily moisturizing) at significantly larger retail scale and lower price points than Progeneron.

TypeBroad incumbent
Description

L'Oréal-owned dermatology-focused skincare brand offering medical-grade cleansers, moisturizers, and therapeutic hand/body products. Comparable as a dermocosmetics positioning play, though at substantially larger scale and broader product range than Progeneron's single-SKU model.

TypeDirect peer
Description

Sanofi-owned topical analgesic brand marketed specifically for arthritis and joint pain relief, including hand and wrist formulations. Closely comparable target indication (arthritic hand pain) and direct-to-consumer retail distribution model.

TypeEmerging player
Description

Topical recovery and cramp/muscle-relief brand sold through mass retail and DTC channels, with a science-backed clinical narrative. Comparable as a smaller emerging player using topical formulations for therapeutic indications with a similar go-to-market structure.

TypeBroad incumbent
Description

L'Oréal-owned dermocosmetics brand specializing in physician-recommended skincare for sensitive and pathological skin conditions. Comparable medical-grade positioning and physician channel strategy, but at global scale and with a deep product portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Progeneron

Topical Dermatological Skincareprogeneron.net

Progeneron is a privately held California-based research company that develops and sells a single surgeon-developed topical hand cream for Palmar Fibromatosis and aging-hand conditions through its own e-commerce store, serving individual consumers in the US and Canada.

What Progeneron does

Progeneron is a privately held research company headquartered in Aliso Viejo, California, that develops and manufactures natural and naturally derived topically applied products for hand and skin conditions. The company's only commercial product is Progeneron Hand Cream, a surgeon-developed daily-use formulation created by founder and Chief Medical Officer Dr. David Scharp, MD, to mitigate the progression and symptoms of Palmar Fibromatosis and to address general aging-hand issues including arthritis pain and reduced range of mobility. The formulation has been evaluated in a 180-day IRB safety study in which 95% of participants showed no signs of disease progression, forming the company's primary clinical evidence platform and differentiating claim.

The company's revenue model is a direct-to-consumer e-commerce operation built on a Shopify storefront at progeneron.net, with fulfillment delegated to Eresina, LLC and shipping handled via FedEx to the United States and Canada. Go-to-market combines consumer-facing content (website, blog, email newsletter) with a parallel physician channel via the Progeneron Physician Portal, where physicians can access clinical data and recommend the product to patients. Pricing is not publicly disclosed; one-time, pay-as-you-go purchase is the only commercial transaction type. The company reports no app, no API surface, no patents or trademarks, no disclosed funding rounds, and no institutional investors.

Progeneron operates as a founder-led micro-business (11-50 employees) with a single-SKU portfolio, a North-American geographic footprint, and no evident institutional capital or third-party scale signals in available sources. Business momentum is anchored almost entirely on the founder's credentials, the IRB study outcome, and a niche, condition-specific value proposition that targets aging-hand consumers and Palmar Fibromatosis patients — a small but underserved therapeutic niche where limited competing therapeutic options exist.

Progeneron firmographics

Firmographics
Name
Progeneron
Legal name
Progeneron, LLC
Website
https://progeneron.net
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Progeneron is a privately held California-based research company that develops and sells a single surgeon-developed topical hand cream for Palmar Fibromatosis and aging-hand conditions through its own e-commerce store, serving individual consumers in the US and Canada.
Ownership category
akta.pro rank

Progeneron industry classification

Industry
Product category
Topical Dermatological Skincare
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro industry
PRIMARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare

Keywords

  • Topical hand cream
  • Palmar fibromatosis treatment
  • Aging hand skincare
  • Physician formulated cream
  • Arthritis hand relief

Where Progeneron is headquartered

Location

Headquarters

HQ city
Aliso Viejo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Progeneron business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. E-commerce Product Sales: Direct-to-consumer sales of Progeneron Hand Cream through their online store. One-time purchase model for topical hand cream products.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goHand cream product pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Progeneron product offering

Product offering

Core offering

Progeneron develops and manufactures Progeneron Hand Cream, a surgeon-developed daily-use topical cream formulated from natural and naturally derived ingredients to mitigate the progression of Palmar Fibromatosis, reduce arthritis pain, and improve range and mobility in aging hands. The product was the subject of a 180-day IRB safety study in which 95% of participants showed no signs of disease progression. Progeneron sells the cream direct-to-consumer through its Shopify-powered e-commerce site and supports physicians with clinical data via a dedicated Physician Portal.

Product overview

Progeneron offers a single core product — the Progeneron Hand Cream. This surgeon-developed daily-use hand cream is designed to mitigate symptoms associated with Palmar Fibromatosis and general aging hands, including arthritis pain and reduced mobility. The company was founded by Dr. David Scharp, MD, and operates as a research company focusing on natural and naturally derived topically applied products for hand and skin conditions. All products are developed and manufactured in the USA.

Differentiator

Problem solved

Functional benefit

Products and services

  • Progeneron Hand Cream A surgeon-developed daily-use hand cream formulated to mitigate the progression and symptoms associated with Palmar Fibromatosis, reduce arthritis pain, and increase range and mobility in aging hands. Subject to a 180-day IRB safety study in which 95% of participants showed no signs of disease progression. Sold direct-to-consumer through the Progeneron website, with clinical data accessible to physicians through a dedicated Physician Portal.

Quantifiable outcome

  • 95% of IRB study participants showed no signs of Palmar Fibromatosis disease progression over 180 days
  • +1 more outcomes

Companies that use Progeneron

Customer profile

Segments3 records

Ideal customer profiles3 records

Progeneron technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Progeneron partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Eresina, LLCcoreOthersEresina, LLC handles order fulfillment and shipping operations for Progeneron. All orders are processed by Eresina, LLC within 3 business days. They are responsible for customs, duties, and taxes processing and currently ship only to United States and Canada.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Progeneron competitors and assessment

Company assessment

Direct peers

  • Biofreeze: Topical pain-relief brand (menthol-based) widely used by chiropractors, physical therapists, and consumers for arthritis and musculoskeletal pain. Comparable as a clinical-channel topical therapy sold through both professional recommendation and retail.
  • Penetrex: Direct-to-consumer topical pain-relief brand targeting joint, muscle, and inflammation-related discomfort. Comparable DTC marketing approach and arthritis-pain value proposition to Progeneron Hand Cream.
  • Blue-Emu: US-based topical pain-relief brand targeting arthritis, joint, and muscle pain with emu-oil-based formulations sold in drugstores and mass retail. Directly comparable as a topical therapy for arthritis and aging-hand symptoms in a similar price-and-channel band.
  • Aspercreme: Sanofi-owned topical analgesic brand marketed specifically for arthritis and joint pain relief, including hand and wrist formulations. Closely comparable target indication (arthritic hand pain) and direct-to-consumer retail distribution model.

Broad incumbents

  • Eucerin: Beiersdorf-owned medical skincare brand with a strong line of therapeutic hand creams and skin-condition products recommended by dermatologists. Directly comparable in the medical-grade hand-care category but with global distribution and a much broader portfolio.
  • Neutrogena: Johnson & Johnson-owned skincare brand with hand and body care lines positioned at the medical-grade end of mass-market skincare. Comparable consumer-skincare category and brand authority, but with vastly greater distribution and product breadth.
  • Gold Bond: Sanofi-owned therapeutic body and hand lotion brand widely distributed in US drugstores and supermarkets. Comparable target consumer (aging hands, daily moisturizing) at significantly larger retail scale and lower price points than Progeneron.
  • CeraVe: L'Oréal-owned dermatology-focused skincare brand offering medical-grade cleansers, moisturizers, and therapeutic hand/body products. Comparable as a dermocosmetics positioning play, though at substantially larger scale and broader product range than Progeneron's single-SKU model.
  • La Roche-Posay: L'Oréal-owned dermocosmetics brand specializing in physician-recommended skincare for sensitive and pathological skin conditions. Comparable medical-grade positioning and physician channel strategy, but at global scale and with a deep product portfolio.

Emerging players

  • Theraworx: Topical recovery and cramp/muscle-relief brand sold through mass retail and DTC channels, with a science-backed clinical narrative. Comparable as a smaller emerging player using topical formulations for therapeutic indications with a similar go-to-market structure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Progeneron social profiles

Digital presence

Progeneron financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Progeneron leadership team

Management profile

Number of profiles

Profiles1 record

Progeneron funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Progeneron M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Progeneron

What does Progeneron do?

Progeneron develops and manufactures Progeneron Hand Cream, a surgeon-developed daily-use topical cream formulated from natural and naturally derived ingredients to mitigate the progression of Palmar Fibromatosis, reduce arthritis pain, and improve range and mobility in aging hands. The product was the subject of a 180-day IRB safety study in which 95% of participants showed no signs of disease progression. Progeneron sells the cream direct-to-consumer through its Shopify-powered e-commerce site and supports physicians with clinical data via a dedicated Physician Portal.

Is Progeneron a public or private company?

Progeneron is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Progeneron founded?

Progeneron was founded in 2016. It employs 11 to 50 people.

Where is Progeneron based?

Progeneron is headquartered in Aliso Viejo, United States, in the North America region.

How does Progeneron make money?

One revenue line is on record: E-commerce Product Sales.

Who are Progeneron's main competitors?

Direct peers on record are Biofreeze, Penetrex, Blue-Emu and Aspercreme. Broad incumbents are Eucerin, Neutrogena, Gold Bond, CeraVe and La Roche-Posay. Theraworx is listed as an emerging player.

Does Progeneron have an API?

No public API is recorded for Progeneron.

What industry is Progeneron in?

Progeneron's product category is Topical Dermatological Skincare. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales